Insider Transactions in Q1 2024 at Optimize Rx Corp (OPRX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Stephen L Silvestro Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,750
+36.12%
|
-
|
|
Mar 01
2024
|
Stephen L Silvestro Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
668
-10.08%
|
$10,020
$15.95 P/Share
|
|
Mar 01
2024
|
Stephen L Silvestro Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,927
+22.54%
|
-
|
|
Mar 01
2024
|
Marion Odence Ford General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
268
-1.85%
|
$4,020
$15.95 P/Share
|
|
Mar 01
2024
|
Marion Odence Ford General Counsel and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
771
+5.05%
|
-
|
|
Feb 15
2024
|
William J Febbo CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+2.64%
|
-
|
|
Feb 15
2024
|
Edward Stelmakh CFO/COO |
BUY
Grant, award, or other acquisition
|
Direct |
7,083
+32.42%
|
-
|
|
Feb 15
2024
|
Marion Odence Ford General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
4,267
+18.74%
|
-
|
|
Feb 15
2024
|
Doug Besch Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+33.76%
|
-
|
|
Feb 11
2024
|
Marion Odence Ford General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,386
-9.17%
|
$20,790
$15.39 P/Share
|
|
Feb 11
2024
|
Marion Odence Ford General Counsel and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+20.93%
|
-
|
|
Jan 09
2024
|
William J Febbo CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,884
-0.6%
|
$37,492
$13.25 P/Share
|
|
Jan 09
2024
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,628
+1.96%
|
-
|
|
Jan 09
2024
|
Marion Odence Ford General Counsel and CCO |
SELL
Open market or private sale
|
Direct |
4,000
-26.47%
|
$60,000
$15.19 P/Share
|